中文
English
About Us
Company
Team
Honor
Vision & Mission
Contact Us
Pipeline
Innovation
Biosimilar
R & D
Antibody Screening
Pharmacodynamics
Protein/Ab Engineering
Process Dev
Multi-functional Fc platform
While the specificity of mAbs are fully appreciated, at the early days, scien...
In vitro/In vivo Pharmaco...
In vitro/In vivo Pharmacology Evaluation Platform in Alphamab including cell b...
Manufacturing
Pilot Production
Quality System
Partnering
Opportunities
Corporation
Academic
News
Press Release
Worth to be Noted
Career
Career opportunity
Apply On-line
News
Press Release
Worth to be Noted
---- Useful Link ----
Alphamab Jilin
DingFu Biotarget
Shihuida Pharma
CFDA
CDE
NIFDC
Worth to be Noted
Home
>
News
>
Worth to be Noted
The market for type 2 diabetes treatments in the Asia-Pacific...
Business intelligence provider GBI Research predicts that the market will grow by $4bn from its 2013 figure of $6.5bn as the number of people with diabetes increases in these regions and access to treatment improves.
Learn More
Science's Breakthrough of the Year 2014
Science's Breakthrough of the Year is the European Space Agency's Rosetta mission to comet 67P/Churyumov-Gerasimenko. In addition to its Breakthrough of the Year, Science named nine runners-up as significant scientific achievement...
Learn More
Worth to be noted
Events
Date
2015年版中国药典内容公示
2014-07-01
清华大学颜宁教授组于世界上首次公布人源葡萄糖转运蛋白（GLUT1）的晶体结构
2014-06-11
GSK以3.5亿美元与Adaptimmune达成癌症药物开发协议
2014-06-05
美国临床肿瘤协会（ASCO）大会在芝加哥召开，肿瘤免疫治疗类新药受到关注
2014-05-30
Ophthotech的抗PDGF药物将进一步影响湿性老年黄斑变性治疗领域
2014-05-26
total17Record，total4Page，Current3Page
Home Page
Pre
Next
End
Home
|
About Us
|
Pipeline
|
R & D
|
Manufacturing
|
Partnering
|
News
|
Career
